Akèy › Miasteni grav › Tennessee › Chattanooga
Etid klinik pou Miasteni grav nan Chattanooga, TN
6 etid pou Miasteni grav ap chèche patisipan nan sit nan ak bò kote Chattanooga (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Ap rekriteFaz 2
- Erlanger Health System, Chattanooga
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Ap rekriteEtid obsèvasyon
- Erlanger Health System, Chattanooga
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Ap rekriteFaz 2
- Erlanger Health System, Chattanooga
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Ap rekriteFaz 3
- Erlanger Health, Inc. - 1123255, Chattanooga
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Ap rekriteFaz 2
- Ut Erlanger Neurology, Chattanooga
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Ap rekriteEtid obsèvasyon
- Clinical Trial Site, Chattanooga
Etid Miasteni grav nan lòt vil
- Tampa, FL12 etid
- Houston, TX11 etid
- Durham, NC10 etid
- Boca Raton, FL10 etid
- Columbus, OH8 etid
- Miami, FL7 etid
- New York City, NY7 etid
- Milwaukee, WI7 etid
- St. Louis, MO7 etid
- Boston, MA6 etid
- Washington, DC6 etid
- San Francisco, CA6 etid
Lòt etid nan Chattanooga
- Kansè Poumon ki pa ti selil11 etid
- Kansè Metastatik6 etid
- Kansè ovè5 etid
- Dyabèt4 etid
- Maladi fwa steatotik4 etid
- Melanom4 etid
- Akidan serebral iskemi4 etid
- Kansè kolorektal4 etid
- Maladi ren kwonik4 etid
- Kansè poumon4 etid
- Ensifizans renn3 etid
- Ateroskleroz3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.